These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 11569620

  • 21. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
    Prinssen EP, Koek W, Colpaert FC, Kleven MS.
    Behav Pharmacol; 2000 Jun; 11(3-4):299-305. PubMed ID: 11103884
    [Abstract] [Full Text] [Related]

  • 22. Effect of 5-HT1A receptor agonist, 8-OH-DPAT, on cough responses in the conscious guinea pig.
    Stone RA, Barnes PJ, Chung KF.
    Eur J Pharmacol; 1997 Aug 06; 332(2):201-7. PubMed ID: 9286622
    [Abstract] [Full Text] [Related]

  • 23. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia.
    Kline AE, Massucci JL, Dixon CE, Zafonte RD, Bolinger BD.
    J Neurotrauma; 2004 Feb 06; 21(2):175-85. PubMed ID: 15000758
    [Abstract] [Full Text] [Related]

  • 24. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF, Szechtman H.
    Behav Pharmacol; 2016 Aug 06; 27(5):439-50. PubMed ID: 26871406
    [Abstract] [Full Text] [Related]

  • 25. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Maswood S.
    Pharmacol Biochem Behav; 1994 Mar 06; 47(3):467-70. PubMed ID: 8208763
    [Abstract] [Full Text] [Related]

  • 26. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 06; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 27. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze.
    Gonzalez LE, Andrews N, File SE.
    Brain Res; 1996 Sep 02; 732(1-2):145-53. PubMed ID: 8891278
    [Abstract] [Full Text] [Related]

  • 28. Circadian rhythm in the hypothermic response to serotonin1A receptor agonist 8-OH-DPAT in rats.
    Lu JQ, Nagayama H.
    Chronobiol Int; 1997 May 02; 14(3):267-73. PubMed ID: 9167887
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R, De Vry J.
    Eur J Pharmacol; 1993 Nov 16; 249(3):341-51. PubMed ID: 7904566
    [Abstract] [Full Text] [Related]

  • 32. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task.
    Pache DM, Sewell RD, Spencer PS.
    J Pharmacol Toxicol Methods; 1999 Aug 16; 41(4):135-41. PubMed ID: 10691017
    [Abstract] [Full Text] [Related]

  • 33. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan 16; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 34. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A, García-Osta A, Ballaz S, Frechilla D, Del Río J.
    Br J Pharmacol; 1999 Dec 16; 128(8):1691-8. PubMed ID: 10588924
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.
    Aguirre N, Ballaz S, Lasheras B, Del Río J.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):181-8. PubMed ID: 9652358
    [Abstract] [Full Text] [Related]

  • 37. Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats.
    Kline AE, Yu J, Massucci JL, Zafonte RD, Dixon CE.
    Neurosci Lett; 2002 Nov 29; 333(3):179-82. PubMed ID: 12429377
    [Abstract] [Full Text] [Related]

  • 38. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse.
    Patel S, Hutson PH.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):197-204. PubMed ID: 8997601
    [Abstract] [Full Text] [Related]

  • 39. Cross state-dependency of learning between 5-HT1A and/or 5-HT7 receptor agonists and muscimol in the mouse dorsal hippocampus.
    Jafari-Sabet M, Nemati S, Torab M.
    J Psychopharmacol; 2019 Jun 19; 33(6):722-736. PubMed ID: 30789290
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice.
    Micheau J, Van Marrewijk B.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug 19; 23(6):1113-33. PubMed ID: 10621953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.